Jiangsu Hengrui Pharmaceuticals (600276.SH) has obtained the notification letter for drug clinical trial approval.
Hengrui Medicine (600276.SH) announced that recently, the company and its subsidiaries Shanghai Hengrui Medicine Co., Ltd., Shanghai Shengdi Medicine Co., Ltd., and Suzhou Shengdi BioPharmaceutical Co., Ltd. received the approval notification for clinical trial batches of SHR-4375 injection, Atezolizumab injection, SHR-8068 injection, Bevacizumab injection, HRS-4642 injection, and SHR-9839 (sc) injection issued by the National Medical Products Administration ("NMPA"). Clinical trials will be conducted in the near future.
Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that recently, the company and its subsidiaries Shanghai Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd., and Suzhou Shengdiya Biopharmaceutical Co., Ltd. have received the approval and issuance of the "Drug Clinical Trial Approval Notice" from the National Medical Products Administration ("NMPA") for SHR-4375 injection, Adabrein single-dose injection, SHR-8068 injection, Bevacizumab injection, HRS-4642 injection, and SHR-9839(sc) for injection. Clinical trials will be conducted soon.
Specifically, a multicenter, open-label Phase I/II clinical study on the safety, tolerability, and effectiveness of SHR-4375 injection in combination with anti-tumor therapy in patients with advanced solid tumors.
Related Articles
C CARBONNEUTRAL(01372): The world's first compliant issuance of carbon coins, with an initial offering of 500 million coins.
On December 29th, LIANLIAN (02598) spent approximately HKD 1.6334 million to repurchase 242,000 shares.
SYNTRUST GK (08629) plans to acquire a construction project testing and inspection service provider for 10.71 million yuan.
C CARBONNEUTRAL(01372): The world's first compliant issuance of carbon coins, with an initial offering of 500 million coins.
On December 29th, LIANLIAN (02598) spent approximately HKD 1.6334 million to repurchase 242,000 shares.
SYNTRUST GK (08629) plans to acquire a construction project testing and inspection service provider for 10.71 million yuan.
